OBI-902 receives consecutive FDA Orphan Drug Designation indication expanded to gastric cancer including gastroesophageal junction...

GSK’227, a B7-H3-targeted antibody-drug conjugate, granted Orphan Drug Designation in small-cell lung cancer by the...

DESTINY-Ovarian01 Phase 3 Trial of ENHERTU initiated as first-line maintenance therapy in patients with HER2...

Biohaven presents clinical safety and efficacy data for BHV-1510, a next-generation Trop2 ADC in...

Korea BNC and ProAbtek jointly develop Albubody’s dual-target next-generation ADC anticancer drug

Oxford BioTherapeutics enters into a strategic collaboration with GSK to discover novel targets for antibody-based...